These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18562513)

  • 1. No evidence for association between the EIF2B5 gene and multiple sclerosis in French families.
    Fogli A; Barbier C; Cournu-Rebeix I; Babron MC; Clerget-Darpoux F; Fontaine B; Boespflug-Tanguy O
    Mult Scler; 2008 May; 14(4):573. PubMed ID: 18562513
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link.
    Zahoor I; Haq E; Asimi R
    Adv Exp Med Biol; 2017; 958():57-64. PubMed ID: 28093708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations identified in EIF2B5 gene in Kashmiri patients as susceptibility factor for multiple sclerosis.
    Zahoor I; Hamid Z; Asimi R; Haq E
    Indian J Biochem Biophys; 2014 Apr; 51(2):115-20. PubMed ID: 24980014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
    Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
    Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.
    Zahoor I; Asimi R; Haq E
    J Neurol Sci; 2015 Dec; 359(1-2):172-6. PubMed ID: 26671108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families.
    Ramagopalan SV; Morrison KM; Para A; Handel A; Disanto G; Handunnetthi L; Orton SM; Sadovnick AD; Ebers GC
    J Neuroimmunol; 2009 Jul; 212(1-2):142-4. PubMed ID: 19428123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics and genetic epidemiology of multiple sclerosis: the "hard facts".
    Sadovnick AD
    Adv Neurol; 2006; 98():17-25. PubMed ID: 16400824
    [No Abstract]   [Full Text] [Related]  

  • 8. The ovarioleukodystrophy.
    Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [eIF2B and Cree Indian leukodystrophies].
    Fogli A; Rodriguez D; Eymard-Pierre E; Boespflug-Tanguy O
    Med Sci (Paris); 2003 Mar; 19(3):283-4. PubMed ID: 12836410
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
    Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
    Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene cluster.
    Feakes R; Chataway J; Sawcer S; Jones HB; Clayton D; Goodfellow PN; Compston A
    Ann Neurol; 1998 Dec; 44(6):984. PubMed ID: 9851448
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Navarro A; Fernández M; Horga A; Montalban X; Comabella M
    J Neuroimmunol; 2009 Aug; 213(1-2):142-7. PubMed ID: 19515430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine mapping of multiple sclerosis susceptibility genes provides evidence of allelic heterogeneity at the IL2RA locus.
    Perera D; Stankovich J; Butzkueven H; Taylor BV; Foote SJ; Kilpatrick TJ; Rubio JP
    J Neuroimmunol; 2009 Jun; 211(1-2):105-9. PubMed ID: 19375175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
    Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple sclerosis--the significance of genes. The Danish Society of Neurology].
    Sellebjerg F; Oturai A; Sørensen PS;
    Ugeskr Laeger; 2008 Mar; 170(12):1046. PubMed ID: 18397664
    [No Abstract]   [Full Text] [Related]  

  • 16. KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis.
    Goris A; Dobosi R; Boonen S; Nagels G; Dubois B
    J Neuroimmunol; 2009 May; 210(1-2):113-5. PubMed ID: 19304328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genetics of clinical outcome in multiple sclerosis.
    Ramagopalan SV; Deluca GC; Degenhardt A; Ebers GC
    J Neuroimmunol; 2008 Sep; 201-202():183-99. PubMed ID: 18632165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism at codon 129 of the prion protein gene is not associated with multiple sclerosis.
    Stüve O; Korth C; Gabatto P; Cameron EM; Hu W; Eagar TN; Monson NL; Frohman EM; Racke MK; Zabetian CP; Oksenberg JR
    Arch Neurol; 2009 Feb; 66(2):280-1. PubMed ID: 19204171
    [No Abstract]   [Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
    J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis and family therapy.
    Field EJ
    Practitioner; 1988 May; 232(1448):503. PubMed ID: 3217358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.